Skip to main

Organ Transplantation and "The role of race and ethnicity in health care crowdfunding: an exploratory analysis"

Organ Transplantation and "The role of race and ethnicity in health care crowdfunding: an exploratory analysis"

AST's Inclusion, Diversity, Equity, and Access to Life (IDEAL) Committee welcomes Drs. Machado, Adekunle, and Spivey to examine racial disparities in health care crowdfunding.

  • 2:00 PM - 3:00 PM EDT
  • Virtual, as part of the AST Journal Club Series.

Panelists

Speaker

Sara Machado, PhD

Brown University School of Public Health
Providence, RI

Moderator

Ruth Adekunle, MD

Medical University of South Carolina
Charleston, SC

Discussant

Christina Spivey, PhD, LMSW

Oregon Health & Science University
Portland, OR

Organ Transplantation and "The role of race and ethnicity in health care crowdfunding: an exploratory analysis
(Health Aff Sch. 2024 Feb 28;2(3):qxae027. doi: 10.1093/haschl/qxae027. eCollection 2024 Mar.)

In this article:
Medical crowdfunding is a key source of financing for individuals facing high out-of-pocket costs, including organ-transplant candidates. However, little is known about racial disparities in campaigning activity and outcomes, or how these relate to access to care. In this exploratory, nationwide, cross-sectional study, [the authors] examined racial disparities in campaigning activity across states and the association between US campaigners’ race and ethnicity and crowdfunding outcomes using a novel database of organ-transplant–related campaigns, and an algorithm to identify race and ethnicity based on name and geographic location. Read more.


Sponsored by AST's Inclusion, Diversity, Equity, and Access to Life (IDEAL) Committee.

Give Back

Make a difference in the field of transplantation by donating to support our cause.

Give

Sign up for AST eNews

This resource for transplant professionals shares AST news events and top articles in transplantation.

Advertisements

This content was developed independently by AST and supported by a financial contribution from Sanofi